Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Star Combo Pharma Ltd. ( (AU:S66) ) has provided an update.
Star Combo Pharma Ltd. has released its Corporate Governance Statement for 2025, outlining its commitment to solid management foundations and oversight. The company has implemented a diversity policy to promote gender equality, with specific objectives for achieving gender diversity within its workforce. As of September 2025, the company reports a 38% female representation across its staff, reflecting its ongoing efforts to enhance workplace diversity.
The most recent analyst rating on (AU:S66) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Star Combo Pharma Ltd. stock, see the AU:S66 Stock Forecast page.
More about Star Combo Pharma Ltd.
Star Combo Pharma Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of health and wellness products. The company emphasizes cultural and gender diversity within its workforce and is committed to maintaining a diverse and inclusive work environment.
Average Trading Volume: 28,218
Technical Sentiment Signal: Buy
Current Market Cap: A$27M
Learn more about S66 stock on TipRanks’ Stock Analysis page.